Cargando…
Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351526/ https://www.ncbi.nlm.nih.gov/pubmed/37465030 http://dx.doi.org/10.2147/CCID.S395353 |
_version_ | 1785074350195474432 |
---|---|
author | David, Michel Braccini, Frederic Garcia, Philippe Loreto, Frederic Benadiba, Laurent Gorj, Mihai Grand-Vincent, Anne Rumyantseva Mathey, Elena Deutsch, Jean-Jacques Ehlinger, Agnès Cartier, Hugues Nadra, Karim Fanian, Ferial |
author_facet | David, Michel Braccini, Frederic Garcia, Philippe Loreto, Frederic Benadiba, Laurent Gorj, Mihai Grand-Vincent, Anne Rumyantseva Mathey, Elena Deutsch, Jean-Jacques Ehlinger, Agnès Cartier, Hugues Nadra, Karim Fanian, Ferial |
author_sort | David, Michel |
collection | PubMed |
description | PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. METHODS: An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. RESULTS: We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. CONCLUSION: AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses. |
format | Online Article Text |
id | pubmed-10351526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103515262023-07-18 Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone David, Michel Braccini, Frederic Garcia, Philippe Loreto, Frederic Benadiba, Laurent Gorj, Mihai Grand-Vincent, Anne Rumyantseva Mathey, Elena Deutsch, Jean-Jacques Ehlinger, Agnès Cartier, Hugues Nadra, Karim Fanian, Ferial Clin Cosmet Investig Dermatol Clinical Trial Report PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. METHODS: An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. RESULTS: We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. CONCLUSION: AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses. Dove 2023-07-13 /pmc/articles/PMC10351526/ /pubmed/37465030 http://dx.doi.org/10.2147/CCID.S395353 Text en © 2023 David et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report David, Michel Braccini, Frederic Garcia, Philippe Loreto, Frederic Benadiba, Laurent Gorj, Mihai Grand-Vincent, Anne Rumyantseva Mathey, Elena Deutsch, Jean-Jacques Ehlinger, Agnès Cartier, Hugues Nadra, Karim Fanian, Ferial Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title | Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title_full | Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title_fullStr | Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title_full_unstemmed | Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title_short | Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone |
title_sort | long-term efficacy and tolerability of a medium g’ ha filler with tri-hyal technology on the rejuvenation of the mobile facial zone |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351526/ https://www.ncbi.nlm.nih.gov/pubmed/37465030 http://dx.doi.org/10.2147/CCID.S395353 |
work_keys_str_mv | AT davidmichel longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT braccinifrederic longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT garciaphilippe longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT loretofrederic longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT benadibalaurent longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT gorjmihai longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT grandvincentanne longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT rumyantsevamatheyelena longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT deutschjeanjacques longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT ehlingeragnes longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT cartierhugues longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT nadrakarim longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone AT fanianferial longtermefficacyandtolerabilityofamediumghafillerwithtrihyaltechnologyontherejuvenationofthemobilefacialzone |